Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.

Levine AP, Chan MMY, Sadeghi-Alavijeh O, Wong EKS, Cook HT, Ashford S, Carss K, Christian MT, Hall M, Harris CL, McAlinden P, Marchbank KJ, Marks SD, Maxwell H, Megy K, Penkett CJ, Mozere M, Stirrups KE, Tuna S, Wessels J, Whitehorn D; MPGN/DDD/C3 Glomerulopathy Rare Disease Group; NIHR BioResource, Johnson SA, Gale DP.

J Am Soc Nephrol. 2020 Jan 9. pii: ASN.2019040433. doi: 10.1681/ASN.2019040433. [Epub ahead of print]

PMID:
31919107
2.

Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions.

Connell A, Montgomery H, Martin P, Nightingale C, Sadeghi-Alavijeh O, King D, Karthikesalingam A, Hughes C, Back T, Ayoub K, Suleyman M, Jones G, Cross J, Stanley S, Emerson M, Merrick C, Rees G, Laing C, Raine R.

NPJ Digit Med. 2019 Jul 31;2:67. doi: 10.1038/s41746-019-0100-6. eCollection 2019.

3.

Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs.

Connell A, Raine R, Martin P, Barbosa EC, Morris S, Nightingale C, Sadeghi-Alavijeh O, King D, Karthikesalingam A, Hughes C, Back T, Ayoub K, Suleyman M, Jones G, Cross J, Stanley S, Emerson M, Merrick C, Rees G, Montgomery H, Laing C.

J Med Internet Res. 2019 Jul 15;21(7):e13147. doi: 10.2196/13147.

4.

Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition.

Sadeghi-Alavijeh O, Henderson S, Bass P, Cook T, DeGroot K, Salama AD.

BMC Nephrol. 2018 Sep 12;19(1):228. doi: 10.1186/s12882-018-1027-x.

5.

Differences in Prevalence of Muscle Weakness (Sarcopenia) in Haemodialysis Patients Determined by Hand Grip Strength Due to Variation in Guideline Definitions of Sarcopenia.

Tangvoraphonkchai K, Hung R, Sadeghi-Alavijeh O, Davenport A.

Nutr Clin Pract. 2018 Apr;33(2):255-260. doi: 10.1002/ncp.10003. Epub 2018 Jan 26.

PMID:
29377324
6.

Chronic kidney disease-associated cardiovascular disease: scope and limitations of animal models.

Sadeghi-Alavijeh O, Tadayyon M, Caplin B.

Cardiovasc Endocrinol. 2017 Nov 15;6(4):120-127. doi: 10.1097/XCE.0000000000000132. eCollection 2017 Dec. Review.

7.

Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury.

Connell A, Montgomery H, Morris S, Nightingale C, Stanley S, Emerson M, Jones G, Sadeghi-Alavijeh O, Merrick C, King D, Karthikesalingam A, Hughes C, Ledsam J, Back T, Rees G, Raine R, Laing C.

Version 2. F1000Res. 2017 Jun 30 [revised 2017 Jan 1];6:1033. doi: 10.12688/f1000research.11637.2. eCollection 2017.

8.

New and developing therapies for AL amyloidosis.

Zumbo G, Sadeghi-Alavijeh O, Hawkins PN, Fontana M.

Expert Opin Pharmacother. 2017 Feb;18(2):139-149. doi: 10.1080/14656566.2016.1274971. Epub 2016 Dec 29. Review.

PMID:
28002971
9.

Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts.

Prendecki M, Blacker E, Sadeghi-Alavijeh O, Edwards R, Montgomery H, Gillis S, Harber M.

Postgrad Med J. 2016 Jan;92(1083):9-13. doi: 10.1136/postgradmedj-2015-133496. Epub 2015 Oct 28.

Supplemental Content

Loading ...
Support Center